Indian researchers have found that oral zinc supplements can reduce the length of common cold, if taken within 24 hours of the first symptoms.
According to pediatricians Rashmi Rajan Das, of the All India Institute of Medical Sciences in Bhubaneswar, and Meenu Singh, of the Post-Graduate Institute of Medical Education and Research in Chandigarh, given the high heterogeneity of data, these results should be interpreted with caution, the New York Daily News reported.
The researchers also said that the prevalence of adverse effects with zinc lozenges is high.
The study also revealed that the preventative use of zinc over a period of five months reduced the incidence of colds in children, but the side effects associated with excessive zinc intake limit the attractiveness of prescribing the supplement to children over an extended period.
The study was published in the Journal of the American Medical Association.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
